1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Immix Biopharma, Inc.

Immix Biopharma, Inc.

IMMX
Immix Biopharma, Inc.US flagNASDAQ Capital Market
9.57
USD
+0.77
- -
520.63MMarket Cap

Income Statement (USD)

APIChatGPT
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
+ Sales & Services Revenue
- -
- -
- -
- -
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- -
- Operating Expenses
1
- -
1
8
16
23
30
+ Selling, General & Admin
- -
- -
1
4
7
11
14
+ Research & Development
1
- -
- -
4
9
11
16
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
-1
- -
-1
-8
-16
-23
-30
- Non-Operating (Income) Loss
- -
1
23
- -
-1
-1
-1
+ Interest Expense, Net
- -
- -
- -
- -
-1
-1
-1
+ Interest Expense
- -
- -
- -
- -
- -
- -
- -
- Interest Income
- -
- -
- -
- -
1
1
1
+ Other Non-Op (Income) Loss
- -
1
23
- -
- -
- -
- -
Pretax Income
-1
-1
-24
-8
-16
-22
-29
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-1
-1
-24
-8
-16
-22
-29
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-1
-1
-24
-8
-15
-22
-29
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-1
-1
-24
-8
-15
-22
-29
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-1
-1
-24
-8
-15
-22
-29
EBIT
-1
- -
-1
-8
-16
-23
-30
EBITDA
-1
- -
-1
-8
-16
-23
-30
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
EBITA
-1
- -
-1
-8
-16
-23
-30
Gross Margin (%)
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
8
9
4
14
17
28
33
Basic EPS, GAAP
-0.12
-0.13
-6.64
-0.59
-0.89
-0.76
-0.89
Basic EPS from Cont Ops
-0.12
-0.13
-6.64
-0.59
-0.9
-0.77
-0.89
Diluted Weighted Avg Shares
8
9
4
14
17
28
33
Diluted EPS, GAAP
-0.12
-0.13
-6.64
-0.59
-0.89
-0.76
-0.89
Diluted EPS from Cont Ops
-0.12
-0.13
-6.64
-0.59
-0.9
-0.77
-0.89

Balance Sheet (USD)

APIChatGPT
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
1
1
18
15
20
20
101
+ Cash, Cash Equivalents & STI
1
- -
18
13
18
18
100
+ Cash & Cash Equivalents
1
- -
18
13
18
18
94
+ ST Investments
- -
- -
- -
- -
- -
- -
6
+ Accounts & Notes Receiv
- -
- -
- -
- -
1
2
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
1
2
- -
+ Inventories
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
- -
1
1
1
1
1
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
- -
- -
- -
- -
3
4
+ Property, Plant & Equip, Net
- -
- -
- -
- -
- -
3
3
+ Property, Plant & Equip
- -
- -
- -
- -
- -
3
4
- Accumulated Depreciation
- -
- -
- -
- -
- -
- -
- -
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
- -
- -
- -
- -
- -
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
- -
- -
- -
- -
Total Assets
1
1
18
15
20
23
105
+ Payables & Accruals
- -
1
- -
1
3
8
9
+ Accounts Payable
- -
- -
- -
- -
1
5
5
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
- -
- -
- -
1
2
3
4
+ ST Debt
4
4
- -
- -
- -
- -
- -
+ ST Borrowings
4
4
- -
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
- -
- -
- -
+ Other ST Liabilities
- -
1
- -
- -
1
1
1
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
1
- -
- -
1
1
1
Total Current Liabilities
5
5
- -
1
4
9
10
+ LT Debt
- -
- -
- -
- -
- -
1
1
+ LT Borrowings
- -
- -
- -
- -
- -
- -
- -
+ LT Finance Leases
- -
- -
- -
- -
- -
1
1
+ Other LT Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Liabilities
- -
- -
- -
- -
- -
1
1
Total Liabilities
5
5
- -
2
4
10
11
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
1
1
48
51
70
88
198
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
1
1
48
51
70
88
198
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-4
-5
-30
-38
-53
-75
-104
+ Other Equity
- -
- -
- -
- -
- -
- -
- -
Equity Before Minority Interest
-4
-5
18
13
16
13
94
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
Total Equity
-4
-5
18
13
16
13
94
Total Liabilities & Equity
1
1
18
15
20
23
105
Shares Outstanding
7
7
13
14
20
28
53
Number of Employees
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
- -
1
1
Net Debt
3
4
-18
-13
-18
-18
-94
Net Debt to Equity
-92.31
-78.4
-97.8
-102.1
-108.06
-133.44
-100.14
Tangible Common Equity Ratio
-386.7
-876.69
98.89
88.27
81.32
57.74
89.47
Current Ratio
0.2
0.1
90.01
11.7
5.32
2.33
10.01
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
-1
-1
-24
-8
-16
-22
-29
+ Depreciation & Amortization
- -
- -
- -
- -
- -
- -
- -
+ Non-Cash Items
- -
1
23
1
3
3
2
+ Stock-Based Compensation
- -
- -
- -
1
3
3
2
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
- -
1
23
- -
- -
- -
- -
+ Chg in Non-Cash Work Cap
- -
- -
- -
- -
2
4
3
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
-1
-1
2
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
-1
-1
- -
1
- -
+ Inc (Dec) in Accts Payable
- -
- -
- -
1
2
4
1
+ Inc (Dec) in Other
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-1
- -
-2
-7
-11
-15
-24
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
- -
- -
-1
-1
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
- -
-1
-1
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
19
3
16
16
107
+ Increase in Capital Stock
- -
- -
19
3
16
16
107
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
- -
- -
-6
+ Dec in LT Investment
- -
- -
- -
- -
- -
- -
- -
+ Inc in LT Investment
- -
- -
- -
- -
- -
- -
-6
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
- -
- -
- -
- -
-1
-7
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
1
- -
- -
- -
- -
- -
- -
+ Cash From Debt
1
- -
- -
- -
- -
- -
- -
+ Repayments of Debt
- -
- -
- -
- -
- -
- -
- -
+ Other Financing Activities
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
1
- -
19
3
15
16
107
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
- -
- -
17
-4
4
- -
76
EBITDA
-1
- -
-1
-8
-16
-23
-30
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow
-1
- -
-2
-7
-11
-16
-25
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
- -
-1
-7
-11
-16
-25
Free Cash Flow per Basic Share
-0.09
-0.05
-0.43
-0.53
-0.66
-0.56
-0.75
Price/Free Cash Flow
- -
- -
-8.23
-4.29
-10.6
-4.64
-7.43
Cash Flow to Net Income
0.81
0.35
0.07
0.9
0.74
0.68
0.81
Capital Expenditures
- -
- -
- -
- -
- -
-1
-1